Key result
Enterovirus-D68 is an emerging respiratory virus associated with acute flaccid myelitis, for which there are currently no effective vaccines or antiviral therapies.
EV-D68 is an emerging enterovirus associated with respiratory disease and acute flaccid myelitis, for which only supportive care is currently available.
Answers are grounded in this paper and cite their sources.
EV-D68 management remains supportive only; leaves open urgent priorities for vaccine and antiviral development.
Enterovirus-D68 (EV-D68) is a unique enterovirus, similar to human rhinoviruses, spread via the respiratory route and primarily causing respiratory disease. Increasing clusters of EV-D68 associated respiratory disease have been reported since 2008, with the largest reported outbreak occurring in North America in 2014. Epidemiologic data and biological plausibility support an association of EV-D68 with the neurologic condition, acute flaccid myelitis. Diagnosis requires EV-D68 specific PCR or viral sequencing of respiratory specimens. Treatment consists of supportive care, as there are no currently available effective vaccines or antiviral therapies. Further research is needed to prepare for future EV-D68 outbreaks of respiratory or neurologic disease.
No takes yet. Share an insight, caveat, or question.
Messacar et al. (2016) conducted a review in Enterovirus-D68 (EV-D68) associated respiratory disease and acute flaccid myelitis. Enterovirus-D68 was evaluated. Enterovirus-D68 is an emerging respiratory virus associated with acute flaccid myelitis, for which there are currently no effective vaccines or antiviral therapies.
Synapse has enriched 10 related papers. Consider them for comparative context: